Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -92.77%-4.07M | -142.12%-1.28M | -77.11%-996.99K | -89.11%-1.14M | -46.78%-696.65K | -1.48%-2.11M | 14.30%-527.76K | 1.19%-562.94K | -95.79%-602.42K | 19.34%-474.62K |
| Net income from continuing operations | -245.37%-10.25M | -221.25%-3.7M | -182.47%-1.69M | -108.47%-1.52M | -579.52%-3.35M | -24.38%-2.97M | -45.12%-1.15M | -7.37%-597.4K | -36.58%-727.89K | 2.24%-493.19K |
| Depreciation and amortization | 121.26%49.36K | 455.90%31.18K | 14.43%6.42K | 9.55%6.13K | 2.53%5.64K | 0.00%22.31K | -0.28%5.61K | -0.27%5.61K | 0.59%5.59K | -0.02%5.5K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | -3,042.10%-295.24K | -5,561.34%-295.24K | --0 | --0 | --0 | 356.39%10.04K | 120.86%5.41K | --0 | --0 | 58.31%-4.63K |
| Remuneration paid in stock | 1,609.07%6.83M | 800.29%3.06M | 4,580.95%647.42K | 19,874.05%560.27K | 5,822.80%2.57M | 174.74%399.84K | 658.14%339.88K | -65.64%13.83K | -89.68%2.81K | 30.22%43.32K |
| Other non cashItems | -62.26%2.4K | 507.15%8.75K | -652.22%-7.71K | -259.87%-2.16K | -82.55%2.16K | --6.35K | --1.44K | --1.4K | --1.35K | --12.39K |
| Change In working capital | -198.02%-409.41K | -242.49%-385.66K | 215.57%43.02K | -260.74%-186.01K | 391.20%80.89K | 300.07%417.69K | 237.11%270.65K | 115.52%13.63K | -38.47%115.72K | 75.10%-27.78K |
| -Change in receivables | -461.51%-407.57K | -530.59%-382.04K | 448.59%48.66K | -284.27%-34.57K | 19.29%-39.61K | 378.20%112.74K | 187.84%88.73K | 284.25%8.87K | -85.59%18.76K | 24.40%-49.08K |
| -Change in prepaid assets | -471.36%-68.74K | -407.25%-49.14K | 115.87%3.03K | 73.63%-3.21K | -157.49%-19.43K | 206.97%18.51K | -36.52%15.99K | -106.20%-19.12K | -295.91%-12.16K | 185.68%33.79K |
| -Change in payables and accrued expense | -76.64%66.9K | -72.56%45.53K | -136.32%-8.67K | -235.84%-148.23K | 1,220.16%139.93K | 289.77%286.44K | 236.47%165.93K | 132.36%23.88K | 111.28%109.12K | -73.00%-12.49K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -92.77%-4.07M | -142.12%-1.28M | -77.35%-998.35K | -89.11%-1.14M | -50.01%-696.65K | -1.48%-2.11M | 14.30%-527.76K | 1.19%-562.94K | -95.79%-602.42K | 21.08%-464.39K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -6,284.44%-41.34M | -28,692.75%-16.23M | -657.63%-2.22M | -636,785.99%-17.86M | -1,613.18%-4.99M | 439.67%668.49K | 70.98%-56.37K | 33,829.07%398K | -100.80%-2.81K | 194.12%329.66K |
| Net PPE purchase and sale | ---31.93K | ---20.93K | ---5.48K | ---- | ---5.52K | --0 | --0 | --0 | ---- | --0 |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | -6,279.67%-41.31M | -28,655.63%-16.21M | -656.25%-2.21M | -636,785.99%-17.86M | -1,611.51%-4.98M | 336.36%668.49K | 70.98%-56.37K | 33,829.07%398K | -100.80%-2.81K | 134,107.32%329.66K |
| Net other investing changes | ---- | ---- | ---- | ---1 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -6,284.44%-41.34M | -28,692.75%-16.23M | -657.63%-2.22M | -636,786.02%-17.86M | -1,613.18%-4.99M | 439.67%668.49K | 70.98%-56.37K | 33,829.07%398K | -100.80%-2.81K | 194.19%329.66K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,680.76%44.3M | 926.19%17.28M | 4,564.83%2.55M | 68,222.32%13.6M | 1,391.37%10.87M | 2.49M | 1.68M | 54.67K | 19.9K | 729K |
| Net issuance payments of debt | ---18.73K | ---- | --0 | ---- | ---- | --0 | ---54.67K | --54.67K | ---- | ---- |
| Net common stock issuance | 1,217.08%11.75M | -7,320.79%-10.25M | --0 | 33,486.78%6.68M | 1,500.48%11.68M | --891.89K | --141.99K | --0 | --19.9K | --730K |
| Proceeds from stock option exercised by employees | 2,043.99%34.24M | 1,625.32%27.56M | --2.55M | --8.14M | ---- | --1.6M | --1.6M | --0 | --0 | ---- |
| Net other financing activities | -138,916.75%-1.67M | --0 | ---- | ---1.23M | -81,041.30%-811.41K | ---1.2K | ---200 | ---- | ---- | ---1K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,680.76%44.3M | 926.19%17.28M | 4,564.83%2.55M | 68,222.33%13.6M | 1,391.37%10.87M | --2.49M | --1.68M | --54.67K | --19.9K | --729K |
| Net cash flow | ||||||||||
| Beginning cash position | 330.70%1.36M | 81.72%471.21K | 208.14%1.14M | 585.22%6.55M | 330.70%1.36M | -87.83%315.63K | -76.96%259.3K | -78.22%369.57K | -42.30%955.39K | -87.83%315.63K |
| Current changes in cash | -206.61%-1.11M | -120.41%-224.56K | -505.42%-667.57K | -823.89%-5.41M | 772.85%5.19M | 145.81%1.04M | 235.81%1.1M | 80.69%-110.27K | -1,530.83%-585.32K | 164.01%594.27K |
| End cash Position | -81.86%246.65K | -81.86%246.65K | 81.72%471.21K | 207.72%1.14M | 619.48%6.55M | 330.70%1.36M | 330.70%1.36M | -76.96%259.3K | -78.19%370.07K | -45.37%909.89K |
| Free cash from | -94.28%-4.1M | -146.09%-1.3M | -78.32%-1M | -89.11%-1.14M | -51.20%-702.17K | 13.12%-2.11M | 14.30%-527.76K | 1.19%-562.94K | -95.79%-602.42K | 50.51%-464.39K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.